No Definite Link Found Between GLP-1 Drugs for Diabetes and Weight Loss and Thyroid Cancer, Says EMA Safety Committee
The European Medicines Agency (EMA) announced on Friday that its safety monitoring group found no definite link between popular GLP-1 drugs used for diabetes and weight loss, such as Ozempic and Wegovy, and thyroid cancer, in following an analysis that lasted several months. The EMA expert committee reviewed the non-clinical, clinical and post-marketing data related … Read more